Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06WNQ
|
|||
| Former ID |
DNCL002242
|
|||
| Drug Name |
TKM-PLK1
|
|||
| Drug Type |
siRNA drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1/2 | [1] | |
| Company |
Tekmira Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02191878) Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma. U.S. National Institutes ofHealth. | |||
| REF 2 | Clinical pipeline report, company report or official report of Arbutus Biopharma. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.